Regardless of industry, the ebb and flow of mergers and acquisitions (M&A) reveal much about companies and their response to competitive, economic and political forces. Currently, the pharmaceutical manufacturing industry is working through an extraordinary period, responding to both dramatic change and incredible opportunity with a surge of M&A activity that has its players seeking to bolster core strengths, market share, strategic competitive agility or all of the above. No matter where you hang your hat in the Pharma industry, it's important to keep up with who's buying whom, who's joining forces, and who's being sold off, especially for those managing production assets because a merger or an acquisition can have such a dramatic and often negative impact on operational excellence and ultimately product quality.

To that end, we offer our own M&A Scorecard, a resource for staying up-to-date on the major players in the industry.